The Addition of EGFR Inhibitors in Neoadjuvant Therapy for KRAS-Wild Type Locally Advanced Rectal Cancer Patients: A Systematic Review and Meta-Analysis
BackgroundPatients with locally advanced rectal cancer (LARC) are at higher risk of local and distant recurrence and are thus more vulnerable to metastatic diseases. Neoadjuvant chemoradiotherapy (nCRT) and subsequent curative resection with total mesorectal excision (TME) followed by adjuvant chemo...
Saved in:
Main Authors: | Xi Zhong (Author), Yue Zhou (Author), Wanbin Cui (Author), Xin Su (Author), Zhexu Guo (Author), Iko Hidasa (Author), Qincai Li (Author), Zhenning Wang (Author), Yongxi Song (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In silico analysis of wild-type and mutant KRAS
by: Frengki Frengki, et al.
Published: (2019) -
Neutrophil Extracellular Trap is Surrogate Biomarker for Prognosis and Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer
by: Zhong W, et al.
Published: (2023) -
The Outcome of Induction Chemotherapy, Followed by Neoadjuvant Chemoradiotherapy and Surgery, in Locally Advanced Rectal Cancer
by: Ali Yaghobi Joybari, et al.
Published: (2021) -
EGFR Inhibitors for Neoadjuvant and Adjuvant Therapy of NSCLC
by: Fabio Villa
Published: (2015) -
The clinical application of ctDNA to predict response to neoadjuvant chemoradiotherapy in patients with locally-advanced rectal cancer
by: Parmida Sadat Pezeshki, et al.
Published: (2023)